Heterogeneous MET gene copy number and EGFR mutation elicit discordant responses to crizotinib between primary and metastatic lesions in erlotinib-resistant lung adenocarcinoma.
Heterogeneous MET gene copy number and EGFR mutation elicit discordant responses to crizotinib between primary and metastatic lesions in erlotinib-resistant lung adenocarcinoma.
复制标题
异质 MET 基因拷贝数和 EGFR 突变导致厄洛替尼耐药肺腺癌的原发灶和转移灶对克唑替尼的反应不一致。
DOI：
10.1016/j.lungcan.2018.03.016
复制
发表时间：
2018
期刊：
影响因子：
5.3
通讯作者：
Suda T
中科院分区：
文献类型：
--
作者：
Yoshimura K;Karayama M;Inoue Y;Kahyo T;Inui N;Maekawa M;Sugimura H;Suda T
